Top global companies by orphan drug revenues 2021
This statistic displays the top pharmaceutical companies worldwide based on sales revenues generated by orphan drugs in 2021. During that year, Bristol Myers Squibb was the world's top company, totaling 22 billion U.S. dollars in orphan drug sales. Orphan drugs are developed to treat a specific rare medical condition, often called an orphan disease. In many countries, public policy determines the characteristics behind specifying orphan diseases and drugs.
